Aridis Pharmaceuticals, Inc.

日期: 2018-08-21
浏览次数: 27

Aridis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases. Complementing the product pipeline is a disruptive platform technology to discover rare, potent human monoclonal antibodies from patients. Its scientists and leadership team have a proven track record of innovation and successful drug development stewardship of therapeutic candidates from early discovery to commercial implementation.Aridis has been listed on Nasdaq in August 2018. 

Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services